Crescentis Capital Rights Issue: ₹80 Crore Plan in 2026

Crescentis Capital Ltd has moved ahead with a proposed rights issue of fully paid-up equity shares worth up to ₹80 crore, including premium. The company’s board approved the fund-raising proposal and the Draft Letter of Offer on September 30, 2026. The proposed issue is subject to statutory, regulatory and other applicable approvals. Crescentis Capital’s shares were reported to have risen 6% over three days following the rights issue approval. The fund raise is intended to strengthen the company’s capital base for its NBFC operations and to repay ₹15 crore of borrowings.

Board Approves Fund Raise

The board approved the issuance of rights equity shares with a face value of ₹10 each. The aggregate amount proposed to be raised is up to ₹80 crore, including any premium. A rights issue allows existing shareholders to subscribe to additional shares in proportion to their holdings, subject to the final entitlement ratio. The company has not yet disclosed the number of shares to be issued. It has also not announced the final issue price. Both details are to be decided under the approved process.

Draft Offer Document Cleared

Alongside the issue approval, Crescentis Capital approved a Draft Letter of Offer. This document is part of the formal process for a rights issue and will be filed with BSE Limited for the relevant approvals. The company said the proposal will be governed by the Companies Act, 2013, the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws. The draft document sets the stage for the company to proceed with the offer after final terms are fixed.

BSE In-Principle Approval Received

Crescentis Capital received in-principle approval from BSE Limited on October 23, 2026. The approval relates to listing of the fully paid-up equity shares proposed under the rights issue. The exchange reference cited by the company is LOD/RIGHT/MV/FIP/1005/2026-27. In-principle approval is an important regulatory step, but it does not itself determine the commercial terms of the issue. The company must still complete the remaining steps, including setting the price, record date and entitlement ratio.

Committee Meeting Set for October 29

The company scheduled a meeting of its Fund-Raising Committee for October 29, 2026. The committee is expected to consider and approve the terms and conditions of the proposed rights issue. Its agenda includes the issue price, payment mechanism, issue size, rights entitlement ratio and record date. The record date will identify shareholders eligible to receive rights entitlements. Crescentis Capital had issued prior intimation of this meeting on October 25, 2026.

Use of Rights Issue Proceeds

According to the company’s disclosure, the proceeds are proposed to augment capital for NBFC operations. The company also plans to use ₹15 crore from the proceeds to repay borrowings. The stated use of funds places the issue in the context of balance-sheet management and operating capital requirements. The precise allocation of the remaining proceeds was not stated in the provided disclosures. Investors will need to refer to the final offer documentation for any additional details on deployment of funds.

Promoters to Subscribe to Entitlement

Crescentis Capital has stated that its promoters will fully subscribe to their rights entitlement. This means the promoters intend to take up the shares available to them under the eventual rights offer. The final promoter subscription amount will depend on the issue price, rights ratio and number of shares offered. The company has not disclosed those terms yet. The commitment remains subject to the final structure of the rights issue.

Comparison With the 2025 Rights Issue

The latest proposal follows a previous rights-based allotment approved in July 2025. At that time, the board approved the allotment of 70,05,579 fully paid-up equity shares on a rights basis. The shares had a face value of ₹10 each and were issued at ₹70 per share, including a premium of ₹60 per share. The current proposal has the same ₹10 face value but its issue price has not been fixed.

What Remains to Be Decided

The company has not announced the record date for the proposed issue. It has also not set the issue price or the rights entitlement ratio. These factors will determine the number of shares available to each eligible shareholder and the amount required for subscription. The payment mechanism and final issue size are also pending committee consideration. Crescentis Capital’s disclosures indicate that these terms are expected to be addressed at the October 29 Fund-Raising Committee meeting.

Market Context and Investor Relevance

The proposed ₹80 crore issue is a capital-raising step for an NBFC-focused business, with part of the funds earmarked for debt repayment. For existing shareholders, the key pending information is the offer price and entitlement ratio. These details will affect the cost of participation and the potential change in the company’s equity capital. The reported 6% share-price move over three days followed the rights issue approval, while the final commercial terms remain unannounced. The next formal update is expected after the committee considers the issue conditions.

Conclusion

Crescentis Capital has secured board approval and BSE’s in-principle approval for a rights issue of up to ₹80 crore. The proposed proceeds are intended to support NBFC operations and repay ₹15 crore of borrowings. The issue price, record date, payment terms and rights entitlement ratio remain pending. The Fund-Raising Committee meeting scheduled for October 29, 2026, is the next identified step in the process.